OpenAlex
PricingAboutJobs
Log inGet started
Author

J. li

Observed name: Jielin Li
Institution: Liaoning Cancer Hospital & Institute
Observed institutions: Shanghai Jiao Tong University, Ruijin Hospital, Liaoning Cancer Hospital & Institute
ORCID: 0000-0002-2368-4797
Observed ORCID: 0000-0002-2368-4797
OpenAlex ID: A5060925145
Dacomitinib overcomes acquired resistance to osimertinib in advanced NSCLC patients with EGFR L718Q mutation: A two-case report
2024 · Jielin Li, Meizi Jin, et al. · Medicine · 2
378P A real-world retrospective analysis of the efficacy of pembrolizumab combined with chemotherapy as neoadjuvant treatment for locally advanced head and neck squamous cell carcinoma (LA HNSCC)
2023 · Z. Liu, D.Z. Li, et al. · Annals of Oncology
PDF
P1119: the Oral Pi3kδ Inhibitor Linperlisib for the Treatment of Relapsed or Refractory Follicular Lymphoma: a Single-arm Multicenter Phase 2 Clinical Trial
2022 · T. wang, X. sun, et al. · HemaSphere
Works count: 3
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms